Deal overview

Deal overview
Price £110.00 Full version or £25.00 Light version
Publication Date Dec 14, 2021
Abstract On 14 December 2021, the quoted Australian pharmaceutical company CSL Limited ("CSL") announced a recommended cash offer for the quoted Swiss company Vifor Pharma AG ("Vifor Pharma"). The cash offer of US$ 179.25 per share, equivalent to CHF 167 per share, valued 100% of Vifor Pharma's equity at CHF 10.9 billion. The offer, which would have a minimum acceptance threshold of ...
Number of pages (Full version) 11
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.015098s